Back to Journals » Cancer Management and Research » Volume 11

The safety and serious adverse events of approved ALK inhibitors in malignancies: a meta-analysis

Total article views   Abstract views HTML views PDF downloads Totals
2,205 Dovepress* 1,567 193+ 589 1,760
PubMed Central* 0 445 186 445
Totals 1,567 638 775 2,205
*Since 7 May 2019
+Since July 2016

View citations on PubMed Central and Google Scholar